LIF and breast carcinoma: The results showed that α-CXCL3 could significantly inhibit the level of LIF mRNA in CAAs induced by breast cancer cells (Figure 7F), and the ELISA results showed that the secretion of LIF in CAAs was inhibited by α-CXCL3 (Figure 7G).